메뉴 건너뛰기




Volumn 107, Issue 6, 2011, Pages 529-537.e2

Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial

Author keywords

[No Author keywords available]

Indexed keywords

ICATIBANT; PLACEBO;

EID: 82955233701     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.08.015     Document Type: Article
Times cited : (196)

References (9)
  • 4
    • 34249801766 scopus 로고    scopus 로고
    • Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
    • DOI 10.1016/j.jaci.2007.02.012, PII S009167490700379X
    • K. Bork, J. Frank, B. Grundt, P. Schlattmann, J. Nussberger, W. Kreuz Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant) J Allergy Clin Immunol 119 2007 1497 1503 (Pubitemid 46855846)
    • (2007) Journal of Allergy and Clinical Immunology , vol.119 , Issue.6 , pp. 1497-1503
    • Bork, K.1    Frank, J.2    Grundt, B.3    Schlattmann, P.4    Nussberger, J.5    Kreuz, W.6
  • 6
    • 79251641987 scopus 로고    scopus 로고
    • Hereditary angioedema: Historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis
    • D.A. Khan Hereditary angioedema: historical aspects, classification, pathophysiology, clinical presentation, and laboratory diagnosis Allergy Asthma Proc 32 2011 1 10
    • (2011) Allergy Asthma Proc , vol.32 , pp. 1-10
    • Khan, D.A.1
  • 7
    • 77957792655 scopus 로고    scopus 로고
    • Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
    • B. Zuraw, M. Cicardi, R.J. Levy Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema J Allergy Clin Immunol 126 2010 821 827
    • (2010) J Allergy Clin Immunol , vol.126 , pp. 821-827
    • Zuraw, B.1    Cicardi, M.2    Levy, R.J.3
  • 8
    • 33748149553 scopus 로고    scopus 로고
    • The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema
    • DOI 10.1517/13543784.15.9.1077
    • J.H. Levy, P.S. O'Donnell The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema Expert Opin Invest Drugs 15 2006 1077 1090 (Pubitemid 44314659)
    • (2006) Expert Opinion on Investigational Drugs , vol.15 , Issue.9 , pp. 1077-1090
    • Levy, J.H.1    O'Donnell, P.S.2
  • 9
    • 77955295556 scopus 로고    scopus 로고
    • Icatibant, a novel bradykinin B2 receptor antagonist, is effective in the treatment of acute attacks in patients with hereditary angioedema
    • M. Cicardi, A. Banerji, F. Bracho Icatibant, a novel bradykinin B2 receptor antagonist, is effective in the treatment of acute attacks in patients with hereditary angioedema N Engl J Med 363 2010 532 541
    • (2010) N Engl J Med , vol.363 , pp. 532-541
    • Cicardi, M.1    Banerji, A.2    Bracho, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.